Gastrointestinal, hepatic and pancreatic disease in cystic fibrosis and nutritional management;Atteintes digestives dans la mucoviscidose et prise en charge nutritionnelle

Revue du Praticien

Volumn 53, Issue 2, 2003, Pages 151-157

  Turck, Dominique ^a   Michaud, Laurent ^a   Wizla Derambure, Nathalie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CYANOCOBALAMIN; PANCREAS EXTRACT; RETINOL; URSODEOXYCHOLIC ACID; VITAMIN D; VITAMIN K GROUP;

ANTHROPOMETRIC PARAMETERS; ARTICLE; AUTOPSY; BILIARY CIRRHOSIS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CAUSE OF DEATH; CHILD GROWTH; CYSTIC FIBROSIS; DELAYED PUBERTY; ENTERIC FEEDING; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GROWTH RETARDATION; HISTOPATHOLOGY; HUMAN; INCIDENCE; LIVER DISEASE; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PANCREAS DISEASE; PANCREAS INSUFFICIENCY; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; SYMPTOMATOLOGY; VITAMIN SUPPLEMENTATION;

EID: 0037439074     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. e édition. Paris: Flammarion Médecine-Sciences, 2000: 551-72.
2. Turck D, Michaud L. Les médicaments des troubles digestifs de la mucoviscidose. In: Pons G, Lenoir G, Navarro J (eds). Les médicaments de la mucoviscidose chez l'enfant. Paris: Springer, 1997: 181-95.
3. Munck A, Navarro J, Debray D, Turck D. Recommandations pour la prise en charge de la mucoviscidose. Prise en charge digestive et nutritionnelle. Arch Pediatr 2001; 8 (Suppl 5): 838s-855s.
4. Smyth RL,Ashby D, O'Hea U et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995; 346: 1247-51.
5. Colombo C, Crosignani A, Battezzati PM. Liver involvement in cystic fibrosis. J Hepatol 1999; 31: 946-54.
6. Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double blind multicenter trial. Hepatology 1996; 23: 1484-90.
7. Debray D,Lykavieris P, Gauthier F et al. Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension. J Hepatol 1999; 31: 77-83.
8. Couetil JP, Houssin DP, Soubrane O et al. Combined lung and liver transplantation in patients with cystic fibrosis: a 4 1/2-year experience. J Thorac Cardiovasc Surg 1995; 110: 1415-23.
9. Vic P, Tassin E,Turck D, Gottrand F, Launay V, Farriaux JP. Fréquence du reflux gastroœsophagien chez le nourrisson et le jeune enfant atteint de mucoviscidose. Arch Pédiatr 1995; 2: 742-6.
10. Malfroot A, Dab I. New insights on gastroœsophageal reflux in CF by longitudinal follow up. Arch Dis Child 1991; 66: 1339-45.
11. Turck D, Michaud L. Cystic fibrosis: nutritional consequences and management. Baillière's Clin Gastroenterol 1998; 12: 805-22.
12. Reilly J, Edwards CA, Weaver LT. Malnutrition in cystic fibrosis: the energy-balance equation. J Pediatr Gastroenterol Nutr 1997; 25: 127-36.
13. Bines JE, Truby HD, Armstrong DS, Phelan PD, Grimwood K. Energy metabolism in infants with cystic fibrosis. J Pediatr 2002; 140: 527-33.
14. Fried MD, Durie PR, Tsui LC et al. The cystic fibrosis gene and resting energy expenditure. J Pediatr 1991; 119: 913-6.
15. Spicher V, Roulet M, Schutz Y. Assessment of total energy expenditure in free-living patients with cystic fibrosis. J Pediatr 1991; 118: 865-72.
16. Beghin L, Michaud L, Loeuille GA et al. Impact of intravenous antibiotic therapy for Pseudomonas aeruginosa pulmonary exacerbation on total daily energy expenditure in cystic fibrosis patients. 34th Annual Meeting of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. Geneva, May 9-12, 2001. J Pediatr Gastroenterol Nutr 2001; 32: 393 (Abstract).
17. Murphy JL,Wootton SA, Bond SA, Jackson AA. Energy content of stools in normal healthy controls and patients with cystic fibrosis. Arch Dis Child 1991; 66: 495-500.
18. Lanng S,Thorsteinsson B, Erichsen G et al. Glucose tolerance in cystic fibrosis. Arch Dis Child 1991; 66: 612-6.
19. Sinaasappel M, Stern M, Littlewood JM et al. Nutrition in patients with cystic fibrosis: a European consensus. J Cystic Fibrosis 2002; 1: 51-75.
20. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35: 246-59.
21. Ellis L, Kalnins D, Corey M, Brennan J, Pencharz P, Durie P. Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study. J Pediatr 1998; 132: 270-6.
22. Marchand V, Baker SS, Stard TJ et al. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2000; 31: 264-9.
23. Hardin DS, Ellis KJ,Dyson M, Rice J, McConnell R, Seilheimer DK. Growth hormone improves clinical status in prepubertal children with cystic fibrosis: result of a randomized controlled triaI. J Pediatr 2001; 139: 636-42.
24. e édition. Paris: Springer, 2002: 901-12.
25. Milla C, Doherty L, Raatz S, Schwarzenberg Sj, Regelmann W, Moran A. Glycemic response to dietary supplements in cystic fibrosis is dependent on the carbohydrate content of the formula. JPEN 1996; 20: 182-6.